| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Reynoso Jamie L. | CEO, Medicare Advantage | C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON | /s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso | 17 Mar 2026 | 0001839066 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLOV | Class A Common Stock | Tax liability | -8,945 | -0.33% | $1.98* | 2,728,755 | 14 Mar 2026 | Direct | F1 | |
| transaction | CLOV | Class A Common Stock | Tax liability | -6,187 | -0.23% | $1.98* | 2,722,568 | 15 Mar 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2026, of the final 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. |
| F2 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. |